Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04956549 · ClinicalTrials.gov registry record · NA
Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)
A NA study of Dementia of Alzheimer Type, sponsored by Pennington Biomedical Research Center.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT04956549: Recruiting NA study of Dementia of Alzheimer Type, sponsored by Pennington Biomedical Research Center.
NCT04956549 is a NA study of Dementia of Alzheimer Type that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 144 participants, below the 639-participant average among 10 other Dementia of Alzheimer Type trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04956549, a NA study of Dementia of Alzheimer Type, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African American adults aged 60 and older will be recruited.
Primary Outcome
The primary outcome measure will be executive function measured by the NIH-Toolbox Cognitive Battery. The NIH Toolbox Executive Function subdomain consists of the Flanker Inhibitory Control and Attention Test and the Dimensional Change Card Sort Test. The Flanker test is a measure of one's ability to inhibit attention to irrelevant conditions. Participants must identify the direction of a central visual stimuli amongst flanking stimuli either congruent or incongruent with the central stimuli. Th
Conditions Studied
Interventions
- BEHAVIORAL Successful Aging
- BEHAVIORAL Physical activity program
Study Locations (1)
Louisiana
- Pennington Biomedical Research - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT04956549 shows while recruiting
NCT04956549 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 639-participant average among 10 other Dementia of Alzheimer Type trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Dementia of Alzheimer Type appearing as the primary indexed condition, and to 2 interventions - of which Successful Aging is the first listed.
NCT04956549 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT04956549 about?
NCT04956549 is a clinical study titled "Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)". The RAATE-MCI proposal is designed to determine the effects of physical activity on risk factors for Alzheimer's Disease in older African American adults. The study will compare a physical activity program to an active control group. RAATE-MCI is a 52-week randomized controlled trial. 144 African Am...
What is the current status of trial NCT04956549?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2021-06-01. Estimated completion is 2027-03-31.
What conditions does trial NCT04956549 study?
This clinical trial studies the following conditions: Dementia of Alzheimer Type.
What interventions are being tested in trial NCT04956549?
The interventions under investigation include: Successful Aging (BEHAVIORAL), Physical activity program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04956549?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04956549 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia of Alzheimer Type
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04956549's enrollment target sits among peer trials
144 5th of 10 higher than 6 of 10 other Dementia of Alzheimer Type trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia of Alzheimer Type trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
ACTIVE NOT RECRUITING · NA
-
Multi-Center Study of Sensory Stimulation to Improve Brain Function
ACTIVE NOT RECRUITING · NA
-
Telehealth-enabled Integrated Palliative Care for People With Dementia
COMPLETED · NA
-
Rural Dementia Caregiver Project
COMPLETED · NA
-
Assess Fibrin in Brains With AD/ADRD
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI